NASDAQ:TMDI

Titan Medical - TMDI Stock Forecast, Price & News

$0.91

+0.05 (+5.84%)

(As of 01/31/2023 12:00 AM ET)

Add

Compare

Today's Range: $0.85
▼
$0.93
50-Day Range: $0.39
▼
$1.01
52-Week Range: $0.38
▼
$1.20

Volume: 88,379 shs
Average Volume: 426,256 shs
Market Capitalization: $101.49 million

P/E Ratio: N/A
Dividend Yield: N/A
Price Target: N/A

Institutional Ownership

About Titan Medical (NASDAQ:TMDI) Stock

Titan Medical, Inc. engages in the research and development of a computer-assisted robotic surgical technology for application in minimally invasive surgery (MIS). Its portfolio, the Enos™ system, is a robotic single access surgery with dual 3D and 2D definition vision systems, multi-articulating instruments, and a surgeon workstation. The company was founded on July 28, 2008 and is headquartered in Toronto, Canada.

Receive TMDI Stock News and Ratings via Email

Sign-up to receive the latest news and ratings for Titan Medical and its competitors with MarketBeat's FREE daily newsletter.

TMDI Stock News Headlines

January 9, 2023 | finance.yahoo.com

Titan Medical Shares Latest Technology Innovation and Announces Meeting Participation During J.P. Morgan Healthcare Conference Week

December 28, 2022 | finance.yahoo.com

Titan Medical Announces Receipt of Nasdaq Listing Determination; Company to Request Hearing

January 31, 2023 | Porter & Company (Ad)

The Next Big Crisis Is Here

You just can’t see it yet because it’s NOT a banking, financial, or economic crisis… it’s far worse and threatens every dollar in your retirement account.

December 6, 2022 | bizjournals.com

Chapel Hill medtech furloughs staff as it weighs potential sale

December 6, 2022 | finance.yahoo.com

Titan Medical Implements Cost-Cutting Measures to Support Strategic Review Process

November 30, 2022 | bizjournals.com

Chapel Hill public company could be looking for a buyer soon

November 30, 2022 | markets.businessinsider.com

Titan Medical To Evaluate Strategic Alternatives

November 30, 2022 | finance.yahoo.com

Titan Medical Announces Commencement of Strategic Review Process

January 31, 2023 | Porter & Company (Ad)

Is This The End of Capitalism?

EXPOSED: The establishment plot to disenfranchise and impoverish millions of Americans…

November 16, 2022 | finance.yahoo.com

Titan Medical Third Quarter 2022 Earnings: US$0.093 loss per share (vs US$0.077 loss in 3Q 2021)

November 10, 2022 | finanznachrichten.de

Titan Medical Inc.: Titan Medical Reports Financial Results for the Third Quarter 2022, and Announces Special Shareholder Meeting

November 10, 2022 | seekingalpha.com

Titan Medical Inc. (TMDI) Q3 2022 Earnings Call Transcript

November 10, 2022 | finance.yahoo.com

Titan Medical Reports Financial Results for the Third Quarter 2022, and Announces Special Shareholder Meeting

November 2, 2022 | finance.yahoo.com

Titan Medical to Issue Third Quarter 2022 Financial Results on November 10, 2022

September 22, 2022 | finance.yahoo.com

Titan Medical Announces Publication of Patent Application Expanding Commitment to Continued Innovation in Single Access Robotic Assisted Surgery

September 14, 2022 | bizjournals.com

Chapel Hill firm extends partnership with $30B medical device giant

August 11, 2022 | seekingalpha.com

Titan Medical Inc. (TMDI) CEO Cary Vance on Q2 2022 Results - Earnings Call Transcript

July 25, 2022 | finance.yahoo.com

Titan Medical to Issue Second Quarter 2022 Financial Results on August 11, 2022

July 10, 2022 | bizjournals.com

New Titan Medical CEO tasked with keeping Chapel Hill firm on track to commercialization

July 1, 2022 | finance.yahoo.com

Chapel Hill company given extension to regain Nasdaq compliance

June 29, 2022 | seekingalpha.com

Titan Medical granted 180-day extension to regain compliance with Nasdaq's minimum bid price rule

June 29, 2022 | finance.yahoo.com

Titan Medical Granted 180-Day Extension by Nasdaq to Regain Compliance with Minimum Bid Price Rule

June 21, 2022 | seekingalpha.com

Titan teams up with Nissha Medical to advance Enos surgical system

June 1, 2022 | finance.yahoo.com

Titan Medical Announces Executive Departure

May 12, 2022 | seekingalpha.com

Titan Medical Inc. (TMDI) CEO Paul Cataford on Q1 2022 Results - Earnings Call Transcript

May 12, 2022 | seekingalpha.com

Titan Medical reports Q1 results

May 12, 2022 | finance.yahoo.com

Titan Medical Reports Financial Results for the First Quarter 2022

See More Headlines

30 days | 90 days | 365 days | Advanced Chart

Receive TMDI Stock News and Ratings via Email

Sign-up to receive the latest news and ratings for Titan Medical and its competitors with MarketBeat's FREE daily newsletter.

TMDI Company Calendar

Last Earnings: 11/10/2022
Today: 1/31/2023
Next Earnings (Estimated): 3/23/2023
Fiscal Year End: 12/31/2023

Get Stock Alerts

Industry, Sector and Symbol

Stock Exchange: NASDAQ
Industry: Surgical & medical instruments
Sub-Industry: N/A
Sector: Medical
Current Symbol: NASDAQ:TMDI
CUSIP: N/A
CIK: 840551
Web: www.titanmedicalinc.com
Phone: (416) 548-7522
Fax: N/A
Employees: 49
Year Founded: N/A

Profitability

EPS (Most Recent Fiscal Year): ($0.19)
Trailing P/E Ratio: N/A
Forward P/E Ratio: N/A
P/E Growth: N/A
Net Income: $-14,860,000.00
Net Margins: N/A
Pretax Margin: -209.87%
Return on Equity: -167.03%
Return on Assets: -112.15%

Debt

Debt-to-Equity Ratio: N/A
Current Ratio: 1.41
Quick Ratio: 1.41

Sales & Book Value

Annual Sales: $10 million
Price / Sales: 10.15
Cash Flow: N/A
Price / Cash Flow: N/A
Book Value: $0.32 per share
Price / Book: 2.83

Miscellaneous

Outstanding Shares: 111,954,000
Free Float: 111,932,000
Market Cap: $101.49 million
Optionable: Not Optionable
Beta: 2.14

Key Executives

Cary Guy Vance
President, Chief Executive Officer & Director

Bill Fahey
Vice President-Manufacturing & Operations

Stephen L. Lemieux
Chief Financial Officer

Deepak Basra
Vice President-Strategy & Business Development

Chien Huang
Vice President-Finance

Key Competitors

View All Competitors

Insiders & Institutions

View All Institutional Transactions

TMDI Stock - Frequently Asked Questions

Should I buy or sell Titan Medical stock right now?: 1 Wall Street analysts have issued "buy," "hold," and "sell" ratings for Titan Medical in the last twelve months. There are currently 1 hold rating for the stock. The consensus among Wall Street analysts is that investors should "hold" TMDI shares. A hold rating indicates that analysts believe investors should maintain any existing positions they have in TMDI, but not buy additional shares or sell existing shares.
View TMDI analyst ratings or view top-rated stocks.
How have TMDI shares performed in 2023?: Titan Medical's stock was trading at $0.6606 at the start of the year. Since then, TMDI shares have increased by 37.2% and is now trading at $0.9065.
View the best growth stocks for 2023 here.
When is Titan Medical's next earnings date?: The company is scheduled to release its next quarterly earnings announcement on Thursday, March 23rd 2023.
View our TMDI earnings forecast.
How were Titan Medical's earnings last quarter?: Titan Medical Inc. (NASDAQ:TMDI) posted its quarterly earnings results on Thursday, November, 10th. The company reported ($0.09) earnings per share for the quarter.

What other stocks do shareholders of Titan Medical own?: Based on aggregate information from My MarketBeat watchlists, some companies that other Titan Medical investors own include NIO (NIO), Advanced Micro Devices (AMD), Electrameccanica Vehicles (SOLO), Sorrento Therapeutics (SRNE), Ampio Pharmaceuticals (AMPE), Biocept (BIOC), Micron Technology (MU), Blink Charging (BLNK), Bionano Genomics (BNGO) and FuelCell Energy (FCEL).
What is Titan Medical's stock symbol?: Titan Medical trades on the NASDAQ under the ticker symbol "TMDI."
Who are Titan Medical's major shareholders?: Titan Medical's stock is owned by many different institutional and retail investors. Top institutional shareholders include Essex LLC (2.55%).
How do I buy shares of Titan Medical?: Shares of TMDI stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include WeBull, Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Robinhood, Fidelity, and Charles Schwab.
Compare Top Brokerages Here.
What is Titan Medical's stock price today?: One share of TMDI stock can currently be purchased for approximately $0.91.
How much money does Titan Medical make?: Titan Medical (NASDAQ:TMDI) has a market capitalization of $101.49 million and generates $10 million in revenue each year. The company earns $-14,860,000.00 in net income (profit) each year or ($0.19) on an earnings per share basis.
How can I contact Titan Medical?: Titan Medical's mailing address is 155 UNIVERSITY AVENUE, TORONTO A6, M5H 3B7. The official website for the company is www.titanmedicalinc.com. The company can be reached via phone at (416) 548-7522.

This page (NASDAQ:TMDI) was last updated on 1/31/2023 by MarketBeat.com Staff

Get 30 Days of MarketBeat All Access Free

Best-in-Class Portfolio Monitoring
View the latest news, buy/sell ratings, SEC filings and insider transactions for your stocks. Compare your portfolio performance to leading indices and get personalized stock ideas based on your portfolio.
Stock Ideas and Recommendations
Get daily stock ideas from top-performing Wall Street analysts. Get short term trading ideas from the MarketBeat Idea Engine. View which stocks are hot on social media with MarketBeat's trending stocks report.
Advanced Stock Screeners and Research Tools
Identify stocks that meet your criteria using seven unique stock screeners. See what's happening in the market right now with MarketBeat's real-time news feed. Export data to Excel for your own analysis.

Start Your 30-Day Free Trial